151 related articles for article (PubMed ID: 27844240)
1. Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer.
Marafie MJ; Dashti M; Al-Mulla F
Fam Cancer; 2017 Jul; 16(3):389-394. PubMed ID: 27844240
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.
Zuhlke KA; Johnson AM; Okoth LA; Stoffel EM; Robbins CM; Tembe WA; Salinas CA; Zheng SL; Xu J; Carpten JD; Lange EM; Isaacs WB; Cooney KA
Fam Cancer; 2012 Dec; 11(4):595-600. PubMed ID: 22864661
[TBL] [Abstract][Full Text] [Related]
3. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
Wokołorczyk D; Kluźniak W; Huzarski T; Gronwald J; Szymiczek A; Rusak B; Stempa K; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C;
Int J Cancer; 2020 Nov; 147(10):2793-2800. PubMed ID: 32875559
[TBL] [Abstract][Full Text] [Related]
4. Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
Escherich CS; Chen W; Li Y; Yang W; Nishii R; Li Z; Raetz EA; Devidas M; Wu G; Nichols KE; Inaba H; Pui CH; Jeha S; Camitta BM; Larsen E; Hunger SP; Loh ML; Yang JJ
Blood; 2024 May; 143(22):2270-2283. PubMed ID: 38446568
[TBL] [Abstract][Full Text] [Related]
5. A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA.
Gass J; Jackson J; Macklin S; Blackburn P; Hines S; Atwal PS
Fam Cancer; 2017 Oct; 16(4):551-553. PubMed ID: 28374160
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
[TBL] [Abstract][Full Text] [Related]
8. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Desjardins S; Beauparlant JC; Labrie Y; Ouellette G; Durocher F;
BMC Cancer; 2009 Jun; 9():181. PubMed ID: 19523210
[TBL] [Abstract][Full Text] [Related]
9. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.
Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ
Cancer Res; 2003 Nov; 63(21):7263-9. PubMed ID: 14612522
[TBL] [Abstract][Full Text] [Related]
10. Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.
Schröder-Heurich B; Bogdanova N; Wieland B; Xie X; Noskowicz M; Park-Simon TW; Hillemanns P; Christiansen H; Dörk T
BMC Cancer; 2014 Jun; 14():434. PubMed ID: 24928521
[TBL] [Abstract][Full Text] [Related]
11. Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?
Zuntini R; Bonora E; Pradella LM; Amato LB; Vidone M; De Fanti S; Catucci I; Cortesi L; Medici V; Ferrari S; Gasparre G; Peterlongo P; Sazzini M; Turchetti D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072463
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity in a newborn with microcephalia: A case report of Nijmegen breakage syndrome.
Cakmak Genc G; Yilmaz B; Karakas Celik S; Aydemir C; Eroz R; Dursun A
Birth Defects Res; 2024 May; 116(5):e2346. PubMed ID: 38761025
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract][Full Text] [Related]
14. The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.
Borecka M; Zemankova P; Lhota F; Soukupova J; Kleiblova P; Vocka M; Soucek P; Ticha I; Kleibl Z; Janatova M
Gene; 2016 Aug; 587(2):169-72. PubMed ID: 27150568
[TBL] [Abstract][Full Text] [Related]
15. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.
Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
[TBL] [Abstract][Full Text] [Related]
16. DNA repair functional analyses of NBN hypomorphic variants associated with NBN-related infertility.
Fiévet A; Bellanger D; Zahed L; Burglen L; Derrien AC; Dubois d'Enghien C; Lespinasse J; Parfait B; Pedespan JM; Rieunier G; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2020 Mar; 41(3):608-618. PubMed ID: 31729086
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing of Finnish hereditary breast cancer families.
Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
[TBL] [Abstract][Full Text] [Related]
19. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
